enVVeno Medical Corp

enVVeno Medical Corp insiders are currently net buyers of NVNO stock, showing neutral sentiment over the past 90 days. Executives have purchased $91.5K while selling $57.7K, resulting in a positive net flow of $33.9K. This buying activity represents 61% of total transaction volume.

enVVeno Medical Corp has 8 active insiders who have filed SEC Form 4 transactions in the past 90 days. Hamed Alavi (Executive) leads with 4 transactions totaling $81.8K. Francis Duhay (Executive) follows with 4 transactions worth $53.4K. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.

The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. enVVeno Medical Corp's current score of 61/100 indicates neutral insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $91.5K in purchases versus $57.7K in sales.

The most recent insider transaction occurred on Dec 11, 2025, when Duhay Francis (Executive) disposed of 4,900 shares at $0.36 per share for $1.8K. This appears to be a discretionary trade.

Based on SEC Form 4 filings from the past 90 days, NVNO insider trading sentiment is currently neutral with an Alignment Score of 61/100. The net insider flow of $33.9K reflects accumulation, with 61% of volume being purchases.

SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like enVVeno Medical Corp. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At NVNO, we track all Form 4 filings—currently showing 23 transactions from 8 insiders over 90 days.

A 10b5-1 plan allows enVVeno Medical Corp executives to pre-schedule stock sales when they don't possess material non-public information. At NVNO, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at NVNO appears discretionary, making insider signals more meaningful.

You can monitor enVVeno Medical Corp (NVNO) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 8 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.

Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. enVVeno Medical Corp's current score of 61/100 indicates moderately bullish sentiment suggesting insider confidence. This is calculated from $91.5K in purchases versus $57.7K in sales over 90 days, resulting in a net flow of $33.9K.

SEC Form 4 filings are mandatory reports that enVVeno Medical Corp insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At NVNO, the most common type is "A" with 10 occurrences. The most recent Form 4 was filed on Dec 11, 2025 by Duhay Francis.

Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At enVVeno Medical Corp, approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at NVNO represents discretionary decisions with more informational value.